JEREMY DAVIS: Open Payments
NPI 1386997351 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$18,711 in 101 payments from 15 companies in 2025. Trend: 2023 $1,923 · 2024 $12,183 · 2025 $18,711
Speaker / faculty: $11,250Food & beverage: $5,220Travel & lodging: $1,392Consulting: $848
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 30 | $12,122 |
| Ipsen Biopharmaceuticals, Inc | 11 | $2,955 |
| Mirum Pharmaceuticals, Inc. | 9 | $1,647 |
| Gilead Sciences, Inc. | 13 | $924 |
| ABBVIE INC. | 11 | $206 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $151 |
| Boston Scientific Corporation | 1 | $150 |
| Phathom Pharmaceuticals, Inc. | 1 | $132 |
| GENZYME CORPORATION | 6 | $131 |
| Janssen Biotech, Inc. | 3 | $120 |
Products named: REZDIFFRA, IQIRVO, Livmarli, ENTYVIO, General - Hemostasis, VOQUEZNA, DUPIXENT, Livdelzi.
Industry payments across LA — which companies pay providers there.
